FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2601000237109: Mass concentration of oxcarbazepine metabolite in serum (observable entity)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Sep 2021. Module: SNOMED CT United Kingdom pathology and laboratory medicine production content extension module

Descriptions:

Id Description Lang Type Status Case? Module
861000237119 Mass concentration of oxcarbazepine metabolite in serum (observable entity) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom pathology and laboratory medicine production content extension module
6681000237118 Oxcarbazepine metabolite mass concentration in serum en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom pathology and laboratory medicine production content extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mass concentration of oxcarbazepine metabolite in serum (observable entity) Is a Observable entity true Inferred relationship Existential restriction modifier
Mass concentration of oxcarbazepine metabolite in serum (observable entity) Direct site Serum specimen true Inferred relationship Existential restriction modifier 1
Mass concentration of oxcarbazepine metabolite in serum (observable entity) Property Mass concentration true Inferred relationship Existential restriction modifier 1
Mass concentration of oxcarbazepine metabolite in serum (observable entity) Inheres in Serum true Inferred relationship Existential restriction modifier 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start